Screener
NovoCure NVCR Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: NovoCure’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001645113-26-000062
| Line item | June 30,2026 | December 31, 2025 |
|---|---|---|
| Trade receivables, net | 99,131 | 89,435 |
| Receivables and prepaid expenses | 46,690 | 58,669 |
| Inventories | 42,224 | 41,111 |
| Total current assets | 638,521 | 646,731 |
| LONG-TERM ASSETS: | ||
| Property and equipment, net | 75,369 | 77,606 |
| Field equipment, net | 26,582 | 22,066 |
| Right-of-use assets | 43,789 | 47,327 |
Item 1. Financial Statements
FAQ
- What is NovoCure's total current assets?
- NovoCure (NVCR) reported total current assets of $638.52M in Q2 2026.
- How has NovoCure's total current assets changed year-over-year?
- NovoCure's total current assets decreased by 41.1% year-over-year, from $1.08B to $638.52M.
- What is the long-term trend for NovoCure's total current assets?
- Over 5 years (2020 to 2025), NovoCure's total current assets has grown at a -8.3% compound annual growth rate (CAGR), from $999.44M to $646.73M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about NovoCure's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude